AXIM Biotechnologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AXIM Biotechnologies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 345% to $39,518. Profit margin reached -20395%. Total operating expenses were $2,790,357.

Profit Margin

AXIM Biotechnologies, Inc. (OTC:AXIM): Profit margin
2014 0 -582.94K
2015 49.13K -10.09M -20539.22%
2016 47.05K -5.80M -12346%
2017 47.57K -4.16M -8761.7%
2018 195.61K -6.75M -3453.05%
2019 799.48K -6.77M -846.98%
2020 0 -6.73M
2021 60.46K -16.51M -27320.76%
2022 8.87K -5.95M -67120.74%
2023 39.51K -8.05M -20394.96%

AXIM Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
39.51K8.87K60.46K0799.48K195.61K47.57K47.05K49.13K0
Cost of revenue
0426.12K016.00K575.69K8.51K42.85K154.13K50.38K0
Gross profit
39.51K-417.25K60.46K-16.00K223.78K187.10K4.71K-107.07K-1.24K0
Operating exp.
Research and development
125.49K153.69K284.86K426.70K2.45M2.05M1.35M235.57K571.45K0
Selling and marketing
0000000000
Total operating expenses
2.79M4.66M7.78M4.83M6.72M5.22M3.15M3.65M10.04M505.72K
Operating income
-2.75M-4.65M-7.98M-4.94M-6.50M-5.03M-3.14M-3.75M-10.04M-505.72K
Other income (expenses), net
-5.30M-1.59M-8.03M-1.34M58.11K-139.53K-1.01M-1.74M-43.22K-32.52K
Income before tax
-8.05M-6.24M-16.02M-6.29M-6.44M-6.75M-4.16M-5.80M-10.09M-538.25K
Income tax expense
0-285.98K493.82K440.10K323.90K1.43M315.01K1.47M044.69K
Net income
-8.05M-5.95M-16.51M-6.73M-6.77M-6.75M-4.16M-5.80M-10.09M-582.94K
Earnings per share
Basic EPS
-0.03-0.03-0.13-0.06-0.11-0.12-0.07-0.14-0.27-0.01
Diluted EPS
-0.03-0.03-0.13-0.06-0.11-0.12-0.07-0.14-0.27-0.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source